Compare Stocks → The Gold Grab of the Century (From Colonial Metals) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:DXRNASDAQ:IINNOTCMKTS:RDGL Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDXRDaxor$9.65-2.9%$8.67$7.11▼$13.13$45.69M-0.463,291 shs1,850 shsIINNInspira Technologies Oxy B.H.N.$1.88-2.6%$1.77$0.76▼$2.49$23.73M2.23990,177 shs112,468 shsRDGLVivos$0.12$0.08$0.04▼$0.12$46.63M1.53734,730 shs1.06 million shs7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDXRDaxor+1.43%+3.43%+12.06%+10.44%+993,999,900.00%IINNInspira Technologies Oxy B.H.N.+3.76%+1.58%+3.76%+105.32%+62.18%RDGLVivos+12.38%+11.95%+73.27%+78.11%+25.93%What is Medicare Supplement Insurance? (Ad)Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you. Learn More HereMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDXRDaxorN/AN/AN/AN/AN/AN/AN/AN/AIINNInspira Technologies Oxy B.H.N.N/AN/AN/AN/AN/AN/AN/AN/ARDGLVivosN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDXRDaxorN/AN/AN/AN/AIINNInspira Technologies Oxy B.H.N.N/AN/AN/AN/ARDGLVivosN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDXRDaxor$1.28M35.68N/AN/AN/A∞IINNInspira Technologies Oxy B.H.N.N/AN/AN/AN/A$0.45 per shareN/ARDGLVivos$20K2,331.28N/AN/A($0.02) per share-6.00Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDXRDaxorN/AN/A0.00∞N/AN/AN/AN/AN/AIINNInspira Technologies Oxy B.H.N.-$11.29MN/A0.00∞N/AN/A-158.18%-108.21%6/24/2024 (Estimated)RDGLVivos-$2.89MN/A0.00∞N/A-9,524.89%N/A-180.12%5/2/2024 (Estimated)Latest IINN, RDGL, and DXR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/18/2024Q4 2023RDGLVivosN/A-$0.01-$0.01-$0.01N/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDXRDaxor$0.030.31%N/AN/AN/AIINNInspira Technologies Oxy B.H.N.N/AN/AN/AN/AN/ARDGLVivosN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDXRDaxorN/AN/AN/AIINNInspira Technologies Oxy B.H.N.0.102.612.61RDGLVivosN/A6.576.57OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDXRDaxor1.34%IINNInspira Technologies Oxy B.H.N.12.72%RDGLVivosN/AInsider OwnershipCompanyInsider OwnershipDXRDaxor60.60%IINNInspira Technologies Oxy B.H.N.29.40%RDGLVivos18.50%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableDXRDaxorN/A4.74 million1.87 millionNot OptionableIINNInspira Technologies Oxy B.H.N.3212.62 million8.91 millionNot OptionableRDGLVivos1388.87 million316.93 millionNot OptionableIINN, RDGL, and DXR HeadlinesSourceHeadlineVivos Inc RDGLmorningstar.com - April 15 at 12:36 AMVivos Therapeutics, Inc: Vivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursementfinanznachrichten.de - April 11 at 5:24 PMVivos Stock (OTC:RDGL), Quotes and News Summarybenzinga.com - March 23 at 12:35 AMVivos Incthestreet.com - February 23 at 7:06 AM3 Stocks to Turn $1,000 Into $1 Million: February 2024investorplace.com - February 22 at 12:39 PMSpeculation Tuesday: 2 Call Options and 1 Penny Stock to Considertheglobeandmail.com - January 31 at 1:26 AMVivos: Unregistered Sales Of Equity Securities, Other Events, Financial Statements And Exhibitscbonds.com - December 29 at 9:59 AMNew Hope In Cancer Battle: FDA Grants Breakthrough Device Status To Vivos Inc.'s RadioGelmsn.com - December 21 at 3:43 PMRadiogel Precision Radionuclide Therapy Receives FDA Breakthrough Device Designationfinance.yahoo.com - December 20 at 1:10 PMRadiogel™ Precision Radionuclide Therapy™ Receives FDA Breakthrough Device Designationfinance.yahoo.com - December 20 at 1:10 PMVivos Inc. Announces Certification of Three New IsoPet® Precision Radionuclide Therapy Regional Clinicsfinance.yahoo.com - August 7 at 10:56 AMCupom de desconto Vivo R$119 Off → (4 Cupons Vivo) Junho 2023catracalivre.com.br - June 21 at 8:15 AMGloboNews ao vivog1.globo.com - May 25 at 10:26 PMVivos Inc. (RDGL) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - May 15 at 10:53 PMCupom Vivo - Maio 2023tecmundo.com.br - May 11 at 10:08 PMIsaura ao vivo na Rádio Observadorobservador.pt - April 29 at 3:54 PMVivo V27 Pro in for reviewgsmarena.com - February 22 at 11:54 PMTrês jovens são retirados vivos dos escombros após 8 dias do terremoto na Turquiabemparana.com.br - February 16 at 2:58 PMVivos Inc Files a New Patent on Alternate Particles for Precision Radionuclide Therapyfinance.yahoo.com - January 11 at 9:39 AMRDGL.PK - Vivos Inc | Stock Price & Latest News | Reutersreuters.com - January 5 at 2:29 PMCupom de desconto Vivo Frete Grátisuai.com.br - January 4 at 11:53 PMVivos Inc Files a New Patent on Precision Radionuclide Therapy Support System Equipmentfinance.yahoo.com - January 3 at 2:06 PMReignite your passion with the vivo Y35philstar.com - October 12 at 8:10 PMVivo 6 GB RAM mobile phones: The ultimate buyer’s guidehindustantimes.com - October 10 at 5:47 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsDaxorNASDAQ:DXRDaxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.Inspira Technologies Oxy B.H.N.NASDAQ:IINNInspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.VivosOTCMKTS:RDGLVivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States and internationally. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.